Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -1.34% | 195.37 | 1.2% | $486.66m | |
| GILD | Gilead Sciences, Inc. | -1.58% | 71.20 | 0.9% | $439.20m | |
| BIIB | Biogen Inc. | -0.78% | 313.07 | 1.3% | $342.01m | |
| ILMN | Illumina, Inc. | -3.74% | 305.37 | 3.5% | $328.61m | |
| CELG | Celgene Corporation | -1.54% | 79.37 | 1.2% | $318.83m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -3.04% | 172.00 | 1.9% | $229.07m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.11% | 379.60 | 2.6% | $219.24m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.00% | 121.45 | 2.0% | $213.77m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.26% | 129.56 | 16.4% | $162.22m | |
| A | Agilent Technologies, Inc. | -3.83% | 61.82 | 1.5% | $149.00m | |
| BMRN | BioMarin Pharmaceutical Inc. | -4.38% | 99.00 | 4.4% | $133.28m | |
| LGND | Ligand Pharmaceuticals Incorporated | -3.21% | 178.95 | 23.3% | $114.41m | |
| EXAS | Exact Sciences Corporation | -2.14% | 60.92 | 25.3% | $103.32m | |
| ECYT | Endocyte, Inc. | -0.09% | 23.50 | 2.1% | $95.77m | |
| NBIX | Neurocrine Biosciences, Inc. | -2.48% | 106.46 | 5.1% | $93.32m |
Company Profile
TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.